Issued Patents All Time
Showing 51–75 of 198 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 11504419 | Individualized vaccines for cancer | Claudia Paret, Kirsten Vormbrock, Christian Bender, Jan Diekmann | 2022-11-22 |
| 11492628 | 3′-UTR sequences for stabilization of RNA | Alexandra Orlandini Von Niessen, Stephanie Fesser, Britta Vallazza, Tim Beissert, Andreas Kuhn +1 more | 2022-11-08 |
| 11473085 | Methods and compositions for diagnosis and treatment of cancer | Ozlem Tureci, Michael Koslowski, Gerd Helftenbein, Korden Walter, Stefan Woll +1 more | 2022-10-18 |
| 11471522 | Methods and compositions for stimulating immune response | Mahjoub Bihi, Mustafa Diken, Thorsten Klamp | 2022-10-18 |
| 11459395 | Binding agents binding to PD-L1 and CD137 and use thereof | Isil Altintas, David Satijn, Rik RADEMAKER, Paul Parren, Friederike Gieseke +4 more | 2022-10-04 |
| 11440966 | Multispecific antibodies against CD40 and CD137 | Isil Altintas, David Satijn, Rik RADEMAKER, Paul Parren, Friederike Gieseke | 2022-09-13 |
| 11395852 | Therapy involving antibodies against Claudin 18.2 for treatment of cancer | Ozlem Tureci | 2022-07-26 |
| 11345731 | Claudin-6-specific immunoreceptors and t cell epitopes | Ozlem Tureci, Petra Simon, Tana Omokoko, Holger Hoff, Ralf-Holger Voss +3 more | 2022-05-31 |
| 11337922 | Lipid particle formulations for delivery of RNA and water-soluble therapeutically effective compounds to a target cell | Hossam Hefesha, Heinrich Haas, Sebastian Kreiter, Yves Hüsemann, Mustafa Diken +1 more | 2022-05-24 |
| 11318195 | Formulation for administration of RNA | Heinrich Haas, Annette Vogel, Daniel Zucker, Stephanie Erbar, Kerstin Walzer +5 more | 2022-05-03 |
| 11311611 | Antigen-specific T cell receptors and T cell epitopes | Ozlem Tureci, Petra Simon, Tana Omokoko | 2022-04-26 |
| 11298426 | Recombinant vaccines and use thereof | Ozlem Tureci, Sebastian Kreiter | 2022-04-12 |
| 11279757 | Antibodies useful in cancer diagnosis | Rita Mitnacht-Kraus, Stefan Woll, Korden Walter, Ozlem Tureci | 2022-03-22 |
| 11248264 | Individualized vaccines for cancer | Sebastian Kreiter, Mustafa Diken, Jan Diekmann, Michael Koslowski, Cedrik Britten +5 more | 2022-02-15 |
| 11222711 | Predicting immunogenicity of T cell epitopes | Arbel David Tadmor, John Castle, Sebastian Boegel, Martin Löwer | 2022-01-11 |
| 11168337 | RNA replicon for versatile and efficient gene expression | Tim Beissert, Mario Perkovic | 2021-11-09 |
| 11156617 | Predicting T cell epitopes useful for vaccination | Martin Löwer, Arbel David Tadmor, Sebastian Boegel, Barbara Schrörs, Mathias Vormehr +1 more | 2021-10-26 |
| 11091557 | Methods of producing multispecific antibodies against CD40 and CD137 | Isil Altintas, David Satijn, Rik RADEMAKER, Paul Parren, Friederike Gieseke | 2021-08-17 |
| 11084882 | Multispecific antibodies against CD40 and CD137 | Isil Altintas, David Satijn, Rik RADEMAKER, Paul Parren, Friederike Gieseke | 2021-08-10 |
| 11046745 | Peptide mimotopes of the CD3 T-cell co-receptor epsilon chain and uses thereof | Laura Marie Kring, Markus Fiedler, Matin Daneschdar, Hans-Ulrich Schmoldt, Ulf Reimer +1 more | 2021-06-29 |
| 11045418 | Lipid particle formulations for delivery of RNA and water-soluble therapeutically effective compounds to a target cell | Hossam Hefesha, Heinrich Haas, Sebastian Kreiter, Yves Hüsemann, Mustafa Diken +1 more | 2021-06-29 |
| 11008550 | Use of RNA for reprogramming somatic cells | Marco Poleganov, Tim Beissert | 2021-05-18 |
| 10968280 | Binding agents binding to PD-L1 and CD137 and use thereof | Isil Altintas, David Satijn, Rik RADEMAKER, Paul Parren, Friederike Gieseke +2 more | 2021-04-06 |
| 10946069 | Combination therapy involving antibodies against claudin 18.2 for treatment of pancreatic cancer | Ozlem Tureci, Rita Mitnacht-Kraus, Stefan Woll, Stefan Jacobs, Cornelia Adriana Maria Heinz | 2021-03-16 |
| 10927413 | Methods and compositions for prediction of therapeutic efficacy of cancer treatments and cancer prognosis | Ozlem Tureci, Daniel Maurus | 2021-02-23 |